Skip to main content

Chen Bihua's Form 4 filing

MoonLake Immunotherapeutics (MLTX) · filed Jun 28, 2023

Accession no.
0000929638-23-001857
Filed
Jun 28, 2023
Trade date
Jun 26, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 27 non-derivative transactions and 0 derivative transactions. Open-market purchases total $20.5M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Chen BihuaCIK 000159921410% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 26, 2023Class A Ordinary SharesPPurchaseAcquired+1,481$36.91+$54,663.713,678,581Indirect
Jun 26, 2023Class A Ordinary SharesPPurchaseAcquired+3,755$38.18+$143,365.93,682,336Indirect
Jun 26, 2023Class A Ordinary SharesPPurchaseAcquired+10,593$39.17+$414,927.813,692,929Indirect
Jun 26, 2023Class A Ordinary SharesPPurchaseAcquired+38,623$39.87+$1,539,899.013,731,552Indirect
Jun 26, 2023Class A Ordinary SharesPPurchaseAcquired+50,642$41.03+$2,077,841.263,782,194Indirect
Jun 26, 2023Class A Ordinary SharesPPurchaseAcquired+61,042$42.12+$2,571,089.043,843,236Indirect
Jun 26, 2023Class A Ordinary SharesPPurchaseAcquired+66,087$43.30+$2,861,567.13,909,323Indirect
Jun 26, 2023Class A Ordinary SharesPPurchaseAcquired+31,558$44.23+$1,395,810.343,940,881Indirect
Jun 26, 2023Class A Ordinary SharesPPurchaseAcquired+10,946$44.93+$491,803.783,951,827Indirect
Jun 26, 2023Class A Ordinary SharesPPurchaseAcquired+37,783$48.93+$1,848,722.193,989,610Indirect
Jun 26, 2023Class A Ordinary SharesPPurchaseAcquired+59,787$49.82+$2,978,588.344,049,397Indirect
Jun 26, 2023Class A Ordinary SharesPPurchaseAcquired+17,662$50.77+$896,699.744,067,059Indirect
Jun 26, 2023Class A Ordinary SharesPPurchaseAcquired+8,697$52.01+$452,330.974,075,756Indirect
Jun 26, 2023Class A Ordinary SharesPPurchaseAcquired+4,725$52.81+$249,527.254,080,481Indirect
Jun 26, 2023Class A Ordinary SharesPPurchaseAcquired+21,823$53.98+$1,178,005.544,102,304Indirect
Jun 26, 2023Class A Ordinary SharesPPurchaseAcquired+18,949$54.92+$1,040,679.084,121,253Indirect
Jun 26, 2023Class A Ordinary SharesPPurchaseAcquired+1,453$55.83+$81,120.994,122,706Indirect
Jun 26, 2023Class A Ordinary SharesPPurchaseAcquired+1,894$56.89+$107,749.664,124,600Indirect
Jun 26, 2023Class A Ordinary SharesPPurchaseAcquired+295$57.63+$17,000.854,124,895Indirect
Jun 26, 2023Class A Ordinary SharesPPurchaseAcquired+1,302$58.98+$76,791.964,126,197Indirect
Jun 26, 2023Class A Ordinary SharesPPurchaseAcquired+417$60.21+$25,107.574,126,614Indirect
Jun 26, 2023Class A Ordinary SharesPPurchaseAcquired+136$62.20+$8,459.24,126,750Indirect
Jun 26, 2023Class A Ordinary SharesPPurchaseAcquired+139$63.85+$8,875.154,126,889Indirect
Jun 26, 2023Class A Ordinary SharesPPurchaseAcquired+95$64.44+$6,121.84,126,984Indirect
Jun 26, 2023Class A Ordinary SharesPPurchaseAcquired+16$65.32+$1,045.124,127,000Indirect
Jun 26, 2023Class A Ordinary SharesPPurchaseAcquired+15$70.62+$1,059.34,127,015Indirect
Jun 26, 2023Class A Ordinary SharesPPurchaseAcquired+85$72.46+$6,159.14,127,100Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)